20-3671681-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025220.5(ADAM33):c.1805A>T(p.Gln602Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000189 in 1,586,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025220.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM33 | ENST00000356518.7 | c.1805A>T | p.Gln602Leu | missense_variant | 16/22 | 1 | NM_025220.5 | ENSP00000348912.3 | ||
ADAM33 | ENST00000379861.8 | c.1805A>T | p.Gln602Leu | missense_variant | 16/22 | 1 | ENSP00000369190.4 | |||
ADAM33 | ENST00000466620.5 | n.1444A>T | non_coding_transcript_exon_variant | 6/11 | 1 | |||||
ADAM33 | ENST00000350009.6 | c.1805A>T | p.Gln602Leu | missense_variant | 16/21 | 5 | ENSP00000322550.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000141 AC: 29AN: 205848Hom.: 0 AF XY: 0.0000540 AC XY: 6AN XY: 111052
GnomAD4 exome AF: 0.0000202 AC: 29AN: 1433998Hom.: 0 Cov.: 35 AF XY: 0.0000127 AC XY: 9AN XY: 711192
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 06, 2024 | The c.1805A>T (p.Q602L) alteration is located in exon 16 (coding exon 16) of the ADAM33 gene. This alteration results from a A to T substitution at nucleotide position 1805, causing the glutamine (Q) at amino acid position 602 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at